Daniel C. Maneval

4.8k citations
69 papers · 3.8k · 1 hit paper · h-index 31

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Cells and Metastasis
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer Research and Treatments

Papers in

    • Cancer Research and Treatments 15
    • Cancer-related Molecular Pathways 7
    • HER2/EGFR in Cancer Research 5

Daniel C. Maneval

66 papers receiving 3.5k citations

Daniel C. Maneval's Hit Papers

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer 2012 · 924 citations
9240+4+9Years since publication250500750

Peers

Daniel C. Maneval
Comparison fields: 5 of 106
  • Oncology 1.7k
  • Biotechnology 523
  • Genetics 841
  • Cancer Research 347
  • Immunology 482
Replace Wouter R. Karthaus with:
Wouter R. Karthaus United States
Willy Landuyt Belgium
Lea Eisenbach Israel
Maria Esperanza Rodriguez-Ruiz Spain
André Pèlegrin France
Deirdre Jill Cohen United States
A. Linn Murphree United States
Kim Monkhorst Netherlands
F. James Primus United States
Kwong Yok Tsang United States
Daniel C. Maneval relative to Wouter R. Karthaus United States Wouter R. Karthaus's profile →
Citations per field
00.5×1.5×1.9×
Wouter R. Karthaus · 1×
Citations per year

Countries citing papers authored by Daniel C. Maneval

Since Specialization
Citations

This map shows the geographic impact of Daniel C. Maneval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Maneval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Maneval more than expected).

Fields of papers citing papers by Daniel C. Maneval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. Maneval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Maneval. The network helps show where Daniel C. Maneval may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel C. Maneval, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel C. Maneval Line = papers co-authored together Daniel C. Maneval links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Hit paper breakdown →
2012924
2 1991267
3 1994216
4 2019136
5 2002113
6 2013108
7
Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
1996105
8
Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
1992101
9
Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
199798
10
Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma.
199694
11 202191
12 199690
13 201190
14 200485
15
p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.
199883
16 201878
17 201773
18
Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
199571
19 200468
20 200267

About Daniel C. Maneval

Daniel C. Maneval is a scholar working on Biotechnology, Oncology, Genetics, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 69 papers that have together received 3.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (21 papers), Cancer Research and Treatments (15 papers), Proteoglycans and glycosaminoglycans research (10 papers), Cancer-related Molecular Pathways (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Radiation Therapy and Dosimetry (5 papers), HER2/EGFR in Cancer Research (5 papers) and Advanced Radiotherapy Techniques (5 papers). The work is most often cited by research in Oncology (1.7k citations), Biotechnology (523 citations), Genetics (841 citations), Cancer Research (347 citations) and Immunology (482 citations). Daniel C. Maneval has collaborated with scholars based in United States, France and Germany. Frequent co-authors include H. Michael Shepard, Harold Michael Shepard, Dennis J. Slamon, Curtis B. Thompson, Ping Jiang, Michael J. LaBarre, Ken N. Wills, Richard J. Gregory, Tomoaki Nakagawa and David Arthur Tuveson. Their work appears in journals such as Physics in Medicine and Biology, Cancer Gene Therapy, IEEE Transactions on Radiation and Plasma Medical Sciences, The Journal of Urology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact